Discovery & Development

A recent US-based study discovered a new compound that could enhance naloxone’s ability to fend off more potent opioids.

The search for an effective treatment for childhood brain cancers goes on, but a modified Herpes virus could represent a breakthrough.

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

We speak with the Alzheimer’s Society in the UK about their work. Find out more with The Medicine Maker

NervGen President and CEO Mike Kelly discusses the potential of the company’s investigational drug NVG-291 for spinal cord injury.

CPHI Milan 2024, the premier global event for pharmaceutical professionals, will take place October 8-10 at Fiera Milano.

ADC development is a complex process that can be streamlined – and optimized – by taking the right partnerships and strategies into consideration.

Remembering the achievements in the short but successful life of insulin co-developer and Nobel Prize laureate Frederick Banting.

Large study shows secondary tumors after CAR-T cancer therapies are rare

How one company is hoping to create a functional cure for HIV